An exchange initiated by the Center for Global Health amongst the Boston University, the Bangladesh Agricultural University, Jimma University Ethiopia, as well as the University of Oslo has led to the set-up of a consortium that by taking a One Health approach looks into whether and how quality and quantity of the antibiotics used in livestock contribute to resistance development.
Architecture and Global Health
From time immemorial, architecture has been an instrument for improving human life. In these times in which the preservation of a healthy life – also together – confronts people with complex global challenges, one discipline alone can no longer offer improvements or solutions.
With this in mind, the first German science consortium “Architecture & Global Health” was founded on 5 July 2019 at the Center for Global Health of the TUM as part of the 3rd working meeting at the Faculty of Architecture of the Technical University of Munich. In the future, this interdisciplinary group of researchers* will promote the generation of knowledge at the interface of the disciplines of medicine, psychology, architecture and health sciences within the framework of joint research projects. The development and testing of suitable research methods and designs will be the first priority. In addition, the association strives to develop, promote and support long-term, sustainable and quality-assured solutions in the context of the increasingly complex issues of global health.
The seven initiators* of the consortium are (in alphabetical order):
Prof. Hannelore Deubzer, Architecture
Prof. Dr. Stefanie Klug, Health Sciences
Mrs. Ir. Gemma Koppen, Architecture
Prof. Dr. Werner Lang, Architecture and Civil Engineering,
Prof. Dr. Prazeres da Costa, Medicine
Prof. Dr. Tanja C. Vollmer, Architectural Psychology
Prof. Dr. Dr. Andrea Winkler, Medicine
The working group Global Neurology / Neuroinfectiology at the Department of Neurology is concerned with neurological diseases that occur in resource-poor regions, in particular in sub-Saharan Africa. These regions suffer from the highest prevalence levels of cerebral infections, such as cerebral malaria, meningitis and parasitic diseases as well as the highest prevalence of people with epilepsy. In addition, neurovascular and neurodegenerative diseases are on the rise. The research of the prevalence as well as other epidemiological aspects of neurological diseases, in addition to the monitoring of the development and response to selected therapeutic measures are the focus of the working group’s research projects. Research findings are communicated with political stakeholders in order to ultimately strengthen health systems, specifically with regards to neurological diseases. This involves amongst others capacity building and further training for colleagues in the regions in question.
Neglected Tropical Diseases
Neglected tropical diseases represent a core focus of the Center for Global Health due to the long-term experience of the two founding directors in this field. The joint project Cystinet-Africa for example is a research network of German and African partners aiming to better understand Taenia solium cysticercosis / taeniosis and to facilitate capacity building as well as data collection and distribution in the involved countries. The project is also mentioned in the brochure on “Global Health in the focus of research – funding concept: neglected and poverty-related diseases” published by the BMBF, the Federal Ministry of Education and Research.
Furthermore, the Center for Global Health together with the Centre for Global Health at the University of Oslo has published a paper on the landscape of neglected tropical diseases at present and in the future for the Series “Global Health in the Era of Agenda 2030”. This series is a collaboration between Norad, the Centre for Global Health at the University of Oslo and the Journal of the Norwegian Medical Association.
The Center for Global Health also participated in a discussion on the global challenges of our nutrition that equally resulted in a publication in the above mentioned Series “Global Health in the Era of 2030” (a collaboration collaboration between Norad, the Centre for Global Health at the University of Oslo and the Journal of the Norwegian Medical Association).
Upper Gastrointestinal Cancers / PYLOTUM
PYLOTUM is a research presence funded by the German Ministry for Education and Research (BMBF). The main goal of this research presence is to promote and enhance the cooperation between the Technische Universität München (TUM) and the Peking University School of Oncology (PUSO)/Peking University Cancer Hospital (PUCH) in 2017. Within PYLOTUM, we have established a Joint Key Laboratory for the study of cancers of the upper gastrointestinal, where we are conducting high-level research in the field.
The lab “Parasite Immunology” at the Institute for Medical Microbiology, Immunology and Hygiene (MIH) at Technical University Munich is offering a PhD student position.
The research in my lab mainly investigates how clinically important human parasites like schistosomes or tapeworms evade the host’s immune system and partly even hijack the adaptive immune system to ensure their own survival and reproduction. Our cell-based studies focus on the induction of regulatory networks such as peripherally induced Treg, alternatively activated macrophages as well as dendritic cells by parasitic molecules and their bystander effects on allergies and vaccines. We employ cutting edge immunological and molecular methodologies, mouse models of disease, in vitro transformation and larval cultivation models amongst many others. We have recently discovered that infection during pregnancy imprints on the capacity of the offspring’s immune system to raise antigen-specific responses e.g. in the context of vaccines. Moving forward, we want to understand this intriguing, possibly Lamarckian process and investigate the underlying mechanisms of how helminth-induced regulatory networks expand to the next generation.
You will be working in a fascinating field that is embedded in a striving and energetic environment, the newly founded Center for Global Health (CGH). It is my personal belief that what you do in your thesis will be a contribution to a neglected disease from which mainly people in low-and-middle income countries (LMIC) suffer. Being the co-founder of the CGH, I want to make sure that you never loose the bird’s eye perspective when you come out of the institute after a long day in the lab.
We are an international team and looking for a highly motivated student with a strong interest in immunology and molecular biology. The successful candidate should have completed a master’s degree (or equivalent), be creative and be committed to interdisciplinary research in a collaborative research environment.
The doctoral candidate will be employed by TUM (65 % TV-L E13) for a total duration of three years (with possible extension) and will be part of TUM graduate school “Experimental Medicine”. TUM is an equal opportunity employer. Therefore, women are especially encouraged to apply. Preference will be given to disabled candidates with essentially the same qualifications.
Please include a CV, brief summary of your previous work experience, a short statement of why you chose to apply for this position and contact information of referees.
Enquiries and applications should be made to email@example.com.